ArticleProceedings of the National Academy of Sciences of the United States of America2023

KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas.

Kayoko Hosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.